MedPath

A trial of neuroprotective vitamin D in traumatic brain injury patients

Phase 3
Conditions
Cerebral trauma.
Intracranial injury
Registration Number
IRCT20191026045243N2
Lead Sponsor
Sari University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
84
Inclusion Criteria

All patients admitted to the emergency department and then transferred to the neurosurgery ward
All patients admitted to the emergency department and then transferred to the ICU ward

Exclusion Criteria

Patients with brain death
Equal degree of vigilance
Patients hospitalized for less than 5 days
Penetrating brain injuries
Accompanying severe lesions
Severe lesions other than brain injuries such as hemothorax or hemo-peritoneum or any injury requiring rapid surgery and no opportunity for neurological examination in the early stages.
itamin D deficiency according to the standard amount reported. And less than 30 ng and more than 60 ng / ml

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evel of consciousness. Timepoint: Baseline and 7 and 90 days. Method of measurement: Glasgow level of consciousness.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath